Upregulation of micro RNA-146a (miRNA-146a), a marker for inflammatory neurodegeneration, in sporadic Creutzfeldt-Jakob disease (sCJD) and Gerstmann-Straussler-Scheinker (GSS) syndrome

J Toxicol Environ Health A. 2011;74(22-24):1460-8. doi: 10.1080/15287394.2011.618973.

Abstract

A mouse- and human-brain-abundant, nuclear factor (NF)-кB-regulated, micro RNA-146a (miRNA-146a) is an important modulator of the innate immune response and inflammatory signaling in specific immunological and brain cell types. Levels of miRNA-146a are induced in human brain cells challenged with at least five different species of single- or double-stranded DNA or RNA neurotrophic viruses, suggesting a broad role for miRNA-146a in the brain's innate immune response and antiviral immunity. Upregulated miRNA-146a is also observed in pro-inflammatory cytokine-, Aβ42 peptide- and neurotoxic metal-induced, oxidatively stressed human neuronal-glial primary cell cocultures, in murine scrapie and in Alzheimer's disease (AD) brain. In AD, miRNA-146a levels are found to progressively increase with disease severity and co-localize to brain regions enriched in inflammatory neuropathology. This study provides evidence of upregulation of miRNA-146a in extremely rare (incidence 1-10 per 100 million) human prion-based neurodegenerative disorders, including sporadic Creutzfeldt-Jakob disease (sCJD) and Gerstmann-Straussler-Scheinker syndrome (GSS). The findings suggest that an upregulated miRNA-146a may be integral to innate immune or inflammatory brain cell responses in prion-mediated infections and to progressive and irreversible neurodegeneration of both the murine and human brain.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid beta-Peptides / pharmacology
  • Amyloid beta-Peptides / therapeutic use*
  • Animals
  • Brain / drug effects
  • Brain / metabolism
  • Brain / pathology
  • Cells, Cultured
  • Creutzfeldt-Jakob Syndrome / drug therapy*
  • Creutzfeldt-Jakob Syndrome / metabolism
  • Creutzfeldt-Jakob Syndrome / pathology
  • Gerstmann-Straussler-Scheinker Disease / drug therapy*
  • Gerstmann-Straussler-Scheinker Disease / metabolism
  • Gerstmann-Straussler-Scheinker Disease / pathology
  • Humans
  • Mice
  • MicroRNAs / drug effects*
  • MicroRNAs / genetics
  • MicroRNAs / metabolism
  • Neurogenic Inflammation / drug therapy*
  • Neurogenic Inflammation / metabolism
  • Neurogenic Inflammation / pathology
  • Neurons / drug effects
  • Neurons / metabolism
  • Neurons / pathology
  • Peptide Fragments / pharmacology
  • Peptide Fragments / therapeutic use*
  • Up-Regulation / drug effects*

Substances

  • Amyloid beta-Peptides
  • MIRN146 microRNA, human
  • MicroRNAs
  • Peptide Fragments
  • amyloid beta-protein (1-42)